Bausch Health Companies Inc.
BHC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000885590
In the last 90 days, Bausch Health Companies Inc. insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $1.18B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $3.10B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $258.9K in total
- 1
- 13F holdersQ2 2026, −7 vs. previous quarter
- 219
- 13F valueReported value at the end of Q2 2026
- $1.18B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $10.3B
- +6.7% year over year
- Net income, FY2025
- $157.0M
- No comparable prior period
- Free cash flow, FY2025
- $1.00B
- −20.4% year over year
- Revenue, Q3 FY2026
- $2.94B
- +9.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 7.41M
- Shares sold short
- Change
- −833.6K
- −10.1% vs. previous
- Days to cover
- 1.24
- At average daily volume
Superinvestors holding BHC, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding BHC at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Bausch Health Companies Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)4:33 PM ET | Aug 19 | 1 day | Lenar Aimee J.President, US Pharma | SSaleCommon Shares, No Par Value | −36.8K | $7.03 | −$258.9K | −9.9%334.9K after | 10b5-1 |
| May 20, 2026 (view filing) | May 19 | 1 day | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −24.5K | $5.43 | −$132.8K | −33.1%49.3K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2-3 | 1 day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −11.3K | $5.78 | −$65.1K | −1.8%616.8K after | 2 lots10b5-1 |
| Feb 27, 2026 (view filing) | Feb 27 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −8.39K | $5.95 | −$49.9K | −1.0%809.3K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Paulson & Co. Inc.10% Owner | PPurchaseCommon Stock, no par value | +2.50M | $6.25 | +$15.6M | +3.5%73.3M after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Carson SeanaEVP, General Counsel | SSaleCommon Shares, No Par Value | −13.4K | $7.31 | −$97.7K | −2.6%499.6K after | 10b5-1 |
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −15.9K | $7.66 | −$121.9K | −17.7%73.8K after | |
| Aug 14, 2025 (view filing) | Aug 14 | Same day | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +34.7M | $9.00 | +$312.5M | +96.4%70.8M after | |
| Aug 13, 2025 (view filing) | Aug 11-13 | 2 days | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +3.24M | $6.56 | +$21.3M | +9.9%36.0M after | 3 lots |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Paulson JohnDirector | PPurchaseCommon Stock, no par value | +3.56M | $5.94 | +$21.2M | +12.2%32.8M after |
Top 10 13F holders, Q2 2026
See all 219 holdersThe largest institutional positions in Bausch Health Companies Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Paulson & Co. Inc. | 73,255,869 | $361.2M | 14.02% | 00.0% | Unchanged |
| Goldentree Asset Management LP | 34,665,731 | $170.7M | 9.92% | 00.0% | Unchanged |
| Royal Bank of Canada | 10,832,582 | $53.4M | 0.01% | −530,916−4.7% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 8,000,000 | $39.4M | 0.06% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 7,465,468 | $36.8M | 0.00% | +61,709+0.8% | Added |
| Geode Capital Management, LLC | 4,803,485 | $33.2M | 0.00% | +574,614+13.6% | Added |
| Goldman Sachs Group Inc | 6,225,131 | $30.7M | 0.00% | +1,017,165+19.5% | Added |
| MFN Partners Management, LP | 6,000,000 | $29.6M | 0.61% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 5,535,771 | $27.3M | 0.02% | +5,520,961+37,278.6% | Added |
| Acadian Asset Management LLC | 5,482,986 | $27.0M | 0.03% | +603,501+12.4% | Added |
Holders of 5% or more of BHC
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Bausch Health Companies Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Paulson & Co. Inc. | 13D/A | 19.10%70.8M shares | +10.20 ppfrom 8.90% | May 21, 20253 filings | Aug 14, 2025 | SEC |
| Meruelo Alex | 13D | 9.99%36.8M shares | – | Apr 23, 20213 filings | Apr 7, 2025 | SEC |
| Goldentree Asset Management LP | 13G/A | 9.50%35.2M shares | – | Feb 13, 20233 filings | Aug 14, 2025 | SEC |
Politician trades
All politician trades in BHC1 member of Congress reported 3 trades in Bausch Health Companies Inc. since 2020. Newest filings:
